Mobile Site ›

Normal View

Unit Code 91518:
HER-2/neu, Quantitative, ELISA

Method Name A short description of the method used to perform the test

Enzyme Linked Immunosorbent Assay (ELISA)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

HER-2/neu Quantitative ELISA

Ordering Mnemonic An alternate Mayo code (to the Unit Code) for a test

FHER

Aliases Lists additional common names for a test, as an aid in searching

Her-2/neu Shed Antigen FORWARD

HER-2/neu, Quantitative FORWARD

Soft-FHER

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Draw blood in a plain, red-top tube(s). (Serum gel tube is

acceptable.) Spin down and send 1mL serum in a

screw-capped vial, shipped frozen.

Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

0.2 mL


The amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

Transport Temperature Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) and unacceptable transport temperature(s) are also included. The preferred transport temperature is listed first, followed by the alternate acceptable temperature (if appropriate) and lastly, the unacceptable transport temperature(s).

Frozen\Refrig NO\Ambient NO

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Hemolysis:                                          Yes

Lipemia:                                               N/A

Icteric:

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

Reference Range:  0.0 - 15.0 ng/mL

 

The Oncogene Science (Cambridge, MA) HER-2 neu test kit

uses an enzyme linked Immunosorbent assay (ELISA) format

to detect and quantitate the HER-2/neu oncoprotein in serum samples.

Studies have shown that elevated levels of serum HER-2/neu

may be associated with clinical parameters such as patient prognosis,

disease progression and resistance to therapy.  Elevated levels

of serum HER-2/neu are observed in a subset of patients with

tumors that overexpress HER-2/neu.  Approximately 25-30% of breast

cancers demonstrate HER-2/neu protein overexpression.

 

The results of this test are not interchangeable with values obtained

by other methods or with other reagents.

 

The results of this test cannot be interpreted as evidence of the presence

or absence of malignant disease, and should only be used in

conjunction with other clinical and diagnostic procedures.

 

Test Performed By:  LabCorp-Research Triangle Park

                                        1912 Alexander Drive

                                         P.O. Box 13973

                                         Research Triangle Park, NC  27709

Clinical Reference Provides recommendations for further in-depth reading of a clinical nature

Fehm T, Malmonis P, Weltz S, et al., Influence of circulating

c-erb-2 serum protein on response to adjuvant chemotherapy

in node-positive breast cancer patients. Breast Cancer Res

Treat 1997 43:87-95.

 

Molina R, Jo J, Fiella et al., c-erb-2 oncoprotein in the sera and

tissue of patients with breast cancer:  Utility in prognosis. Anti-

cancer Research 1996 16:2295-2300.

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Tuesday, Friday

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

3 days

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

4-8 days

Performing Laboratory Location The location of the laboratory that performs the test

LabCorp RTP

List Fee Provides the Mayo Medical Laboratories list fee for performing the test

$211.20

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each unit code or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

83950